Frank Biotic Remedies (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth -65.08%
- Profit Growth -107.79%
- Ebitda -107.33%
- Net Worth -2.06%
- Total Assets -13.40%
About Frank Biotic Remedies (India)
Frank Biotic Remedies (India) Limited (FBRIL) is a Public Limited Indian Non-Government Company incorporated in India on 20 December 2011 and has a history of 13 years and two months. Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Mandal, Jai Mandal, Subodh Mandal, and One other member serve as directors at the Company.
Company Details
- Location
Faridabad, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33119HR2011PLC044636
- Company No.
044636
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2011
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Frank Biotic Remedies (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jai Mandal  | Managing Director | 20-Dec-2011 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subodh Mandal | Director | 20-Dec-2011 | Current |
| Renu Mandal | Director | 20-Dec-2011 | Current |
| Santosh Mandal | Director | 20-Dec-2011 | Current |
Financial Performance of Frank Biotic Remedies (India).
Frank Biotic Remedies (India) Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 65.08% decrease. The company also saw a substantial fall in profitability, with a 107.79% decrease in profit. The company's net worth dipped by a decrease of 2.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Frank Biotic Remedies (India)?
In 2017, Frank Biotic Remedies (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Frank Biotic Remedies (India)?
Unlock and access historical data on people associated with Frank Biotic Remedies (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Frank Biotic Remedies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Frank Biotic Remedies (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.